| UniProt ID | THOP1_HUMAN | |
|---|---|---|
| UniProt AC | P52888 | |
| Protein Name | Thimet oligopeptidase | |
| Gene Name | THOP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 689 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Involved in the metabolism of neuropeptides under 20 amino acid residues long. Involved in cytoplasmic peptide degradation. Able to degrade the amyloid-beta precursor protein and generate amyloidogenic fragments.. | |
| Protein Sequence | MKPPAACAGDMADAASPCSVVNDLRWDLSAQQIEERTRELIEQTKRVYDQVGTQEFEDVSYESTLKALADVEVTYTVQRNILDFPQHVSPSKDIRTASTEADKKLSEFDVEMSMREDVYQRIVWLQEKVQKDSLRPEAARYLERLIKLGRRNGLHLPRETQENIKRIKKKLSLLCIDFNKNLNEDTTFLPFTLQELGGLPEDFLNSLEKMEDGKLKVTLKYPHYFPLLKKCHVPETRRKVEEAFNCRCKEENCAILKELVTLRAQKSRLLGFHTHADYVLEMNMAKTSQTVATFLDELAQKLKPLGEQERAVILELKRAECERRGLPFDGRIRAWDMRYYMNQVEETRYCVDQNLLKEYFPVQVVTHGLLGIYQELLGLAFHHEEGASAWHEDVRLYTARDAASGEVVGKFYLDLYPREGKYGHAACFGLQPGCLRQDGSRQIAIAAMVANFTKPTADAPSLLQHDEVETYFHEFGHVMHQLCSQAEFAMFSGTHVERDFVEAPSQMLENWVWEQEPLLRMSRHYRTGSAVPRELLEKLIESRQANTGLFNLRQIVLAKVDQALHTQTDADPAEEYARLCQEILGVPATPGTNMPATFGHLAGGYDAQYYGYLWSEVYSMDMFHTRFKQEGVLNSKVGMDYRSCILRPGGSEDASAMLRRFLGRDPKQDAFLLSKGLQVGGCEPEPQVC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Ubiquitination | ------MKPPAACAG ------CCCCCCCCC | 60.76 | 24816145 | |
| 2 | Acetylation | ------MKPPAACAG ------CCCCCCCCC | 60.76 | 25953088 | |
| 7 | Ubiquitination | -MKPPAACAGDMADA -CCCCCCCCCCCCCC | 4.77 | 22817900 | |
| 11 | Ubiquitination | PAACAGDMADAASPC CCCCCCCCCCCCCCC | 3.39 | 21890473 | |
| 16 | Phosphorylation | GDMADAASPCSVVND CCCCCCCCCCHHHHH | 28.32 | 23401153 | |
| 19 | Phosphorylation | ADAASPCSVVNDLRW CCCCCCCHHHHHHHC | 32.27 | 29255136 | |
| 30 | Ubiquitination | DLRWDLSAQQIEERT HHHCCCCHHHHHHHH | 16.76 | 24816145 | |
| 45 | Ubiquitination | RELIEQTKRVYDQVG HHHHHHHHHHHHHHC | 39.29 | 21890473 | |
| 49 | Ubiquitination | EQTKRVYDQVGTQEF HHHHHHHHHHCCCCC | 33.56 | 21890473 | |
| 49 | Acetylation | EQTKRVYDQVGTQEF HHHHHHHHHHCCCCC | 33.56 | - | |
| 70 | Ubiquitination | STLKALADVEVTYTV HHHHHHCCCEEEEEE | 37.65 | 21890473 | |
| 89 | Phosphorylation | LDFPQHVSPSKDIRT CCCCCCCCCCCCHHH | 22.72 | 28450419 | |
| 91 | Phosphorylation | FPQHVSPSKDIRTAS CCCCCCCCCCHHHCC | 35.14 | 28450419 | |
| 92 | Ubiquitination | PQHVSPSKDIRTAST CCCCCCCCCHHHCCH | 61.63 | 29967540 | |
| 92 | Acetylation | PQHVSPSKDIRTAST CCCCCCCCCHHHCCH | 61.63 | 25953088 | |
| 99 | Phosphorylation | KDIRTASTEADKKLS CCHHHCCHHHHHHHH | 32.50 | - | |
| 103 | Ubiquitination | TASTEADKKLSEFDV HCCHHHHHHHHHCCC | 63.76 | - | |
| 104 | Ubiquitination | ASTEADKKLSEFDVE CCHHHHHHHHHCCCC | 58.77 | 24816145 | |
| 108 | Ubiquitination | ADKKLSEFDVEMSMR HHHHHHHCCCCHHHC | 13.17 | 21963094 | |
| 128 | Ubiquitination | RIVWLQEKVQKDSLR HHHHHHHHHHHCCCC | 36.68 | 29967540 | |
| 131 | Ubiquitination | WLQEKVQKDSLRPEA HHHHHHHHCCCCHHH | 52.88 | 29967540 | |
| 139 | Ubiquitination | DSLRPEAARYLERLI CCCCHHHHHHHHHHH | 10.05 | - | |
| 141 | Phosphorylation | LRPEAARYLERLIKL CCHHHHHHHHHHHHH | 14.27 | - | |
| 147 | Ubiquitination | RYLERLIKLGRRNGL HHHHHHHHHHHHCCC | 49.86 | 27667366 | |
| 165 | Acetylation | RETQENIKRIKKKLS HHHHHHHHHHHHHHC | 60.70 | 25953088 | |
| 170 | Ubiquitination | NIKRIKKKLSLLCID HHHHHHHHHCCEEEE | 38.00 | - | |
| 172 | Phosphorylation | KRIKKKLSLLCIDFN HHHHHHHCCEEEECC | 28.33 | 28450419 | |
| 216 | Ubiquitination | KMEDGKLKVTLKYPH HCCCCCEEEEEECCC | 36.34 | 22817900 | |
| 220 | Ubiquitination | GKLKVTLKYPHYFPL CCEEEEEECCCHHHH | 47.58 | 21963094 | |
| 221 | Phosphorylation | KLKVTLKYPHYFPLL CEEEEEECCCHHHHH | 9.80 | 20090780 | |
| 224 | Phosphorylation | VTLKYPHYFPLLKKC EEEECCCHHHHHHHC | 11.46 | 28152594 | |
| 229 | Acetylation | PHYFPLLKKCHVPET CCHHHHHHHCCCCHH | 62.12 | 19608861 | |
| 230 | Ubiquitination | HYFPLLKKCHVPETR CHHHHHHHCCCCHHH | 29.55 | - | |
| 236 | Ubiquitination | KKCHVPETRRKVEEA HHCCCCHHHHHHHHH | 29.69 | - | |
| 239 | Acetylation | HVPETRRKVEEAFNC CCCHHHHHHHHHHHC | 51.19 | 19811663 | |
| 239 | Ubiquitination | HVPETRRKVEEAFNC CCCHHHHHHHHHHHC | 51.19 | 24816145 | |
| 244 | Ubiquitination | RRKVEEAFNCRCKEE HHHHHHHHHCCCCHH | 11.38 | - | |
| 249 | Acetylation | EAFNCRCKEENCAIL HHHHCCCCHHHHHHH | 49.03 | 23749302 | |
| 257 | Ubiquitination | EENCAILKELVTLRA HHHHHHHHHHHHHHH | 42.78 | 19608861 | |
| 257 | Acetylation | EENCAILKELVTLRA HHHHHHHHHHHHHHH | 42.78 | 19608861 | |
| 267 | Phosphorylation | VTLRAQKSRLLGFHT HHHHHHHHHHCCCCC | 18.97 | 23663014 | |
| 274 | Phosphorylation | SRLLGFHTHADYVLE HHHCCCCCCHHHHHH | 19.25 | 23663014 | |
| 278 | Phosphorylation | GFHTHADYVLEMNMA CCCCCHHHHHHHHHH | 14.02 | 23663014 | |
| 287 | Phosphorylation | LEMNMAKTSQTVATF HHHHHHCCHHHHHHH | 19.27 | 30624053 | |
| 288 | Phosphorylation | EMNMAKTSQTVATFL HHHHHCCHHHHHHHH | 24.13 | 30624053 | |
| 290 | Phosphorylation | NMAKTSQTVATFLDE HHHCCHHHHHHHHHH | 16.33 | 30624053 | |
| 293 | Phosphorylation | KTSQTVATFLDELAQ CCHHHHHHHHHHHHH | 22.01 | 30624053 | |
| 301 | Ubiquitination | FLDELAQKLKPLGEQ HHHHHHHHHHCCCHH | 53.52 | 30230243 | |
| 303 | Ubiquitination | DELAQKLKPLGEQER HHHHHHHHCCCHHHH | 45.27 | 29967540 | |
| 317 | Ubiquitination | RAVILELKRAECERR HHHHHHHHHHHHHHC | 39.94 | 21963094 | |
| 329 | Ubiquitination | ERRGLPFDGRIRAWD HHCCCCCCCCEEHHH | 43.45 | 21890473 | |
| 339 | Phosphorylation | IRAWDMRYYMNQVEE EEHHHHHHHHHHHHH | 10.63 | 21406692 | |
| 340 | Phosphorylation | RAWDMRYYMNQVEET EHHHHHHHHHHHHHH | 4.53 | 21406692 | |
| 347 | Phosphorylation | YMNQVEETRYCVDQN HHHHHHHHHEECCHH | 17.27 | 20068231 | |
| 350 | Ubiquitination | QVEETRYCVDQNLLK HHHHHHEECCHHHHH | 2.15 | 21963094 | |
| 412 | Phosphorylation | GEVVGKFYLDLYPRE CCEEEEEEEECCCCC | 11.64 | 20068231 | |
| 416 | Phosphorylation | GKFYLDLYPREGKYG EEEEEECCCCCCCCC | 10.42 | 28152594 | |
| 419 | Ubiquitination | YLDLYPREGKYGHAA EEECCCCCCCCCCCH | 56.38 | 27667366 | |
| 421 | Ubiquitination | DLYPREGKYGHAACF ECCCCCCCCCCCHHC | 43.22 | - | |
| 422 | Phosphorylation | LYPREGKYGHAACFG CCCCCCCCCCCHHCC | 25.63 | 28152594 | |
| 427 | Ubiquitination | GKYGHAACFGLQPGC CCCCCCHHCCCCCCC | 2.63 | 24816145 | |
| 527 | Phosphorylation | RMSRHYRTGSAVPRE HHCHHHCCCCCCCHH | 28.46 | 29449344 | |
| 529 | Phosphorylation | SRHYRTGSAVPRELL CHHHCCCCCCCHHHH | 26.02 | 29449344 | |
| 538 | Ubiquitination | VPRELLEKLIESRQA CCHHHHHHHHHHCCC | 55.52 | 22053931 | |
| 538 | Acetylation | VPRELLEKLIESRQA CCHHHHHHHHHHCCC | 55.52 | 19608861 | |
| 559 | Ubiquitination | LRQIVLAKVDQALHT HHHHHHHHHHHHHHC | 42.03 | 21906983 | |
| 628 | Ubiquitination | DMFHTRFKQEGVLNS CCCCHHHHHCCCCCC | 44.12 | 27667366 | |
| 628 | Acetylation | DMFHTRFKQEGVLNS CCCCHHHHHCCCCCC | 44.12 | 26051181 | |
| 636 | Ubiquitination | QEGVLNSKVGMDYRS HCCCCCCCCCCCHHH | 41.56 | 24816145 | |
| 641 | Phosphorylation | NSKVGMDYRSCILRP CCCCCCCHHHCCCCC | 8.78 | - | |
| 643 | Phosphorylation | KVGMDYRSCILRPGG CCCCCHHHCCCCCCC | 10.16 | 10969067 | |
| 667 | Ubiquitination | RFLGRDPKQDAFLLS HHHCCCCCCCCCHHH | 66.16 | 29967540 | |
| 675 | Ubiquitination | QDAFLLSKGLQVGGC CCCCHHHCCCCCCCC | 64.71 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 643 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 643 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of THOP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of THOP1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| VAV2_HUMAN | VAV2 | physical | 22939629 | |
| TIM9_HUMAN | TIMM9 | physical | 22939629 | |
| TT39C_HUMAN | TTC39C | physical | 22939629 | |
| XYLB_HUMAN | XYLB | physical | 22939629 | |
| UBE2H_HUMAN | UBE2H | physical | 22939629 | |
| UAP1_HUMAN | UAP1 | physical | 22939629 | |
| UNG_HUMAN | UNG | physical | 22939629 | |
| PURA2_HUMAN | ADSS | physical | 22863883 | |
| ANXA6_HUMAN | ANXA6 | physical | 22863883 | |
| CHRC1_HUMAN | CHRAC1 | physical | 22863883 | |
| CH60_HUMAN | HSPD1 | physical | 22863883 | |
| CH10_HUMAN | HSPE1 | physical | 22863883 | |
| IDHC_HUMAN | IDH1 | physical | 22863883 | |
| NDKA_HUMAN | NME1 | physical | 22863883 | |
| 6PGD_HUMAN | PGD | physical | 22863883 | |
| PLST_HUMAN | PLS3 | physical | 22863883 | |
| PTMS_HUMAN | PTMS | physical | 22863883 | |
| RBBP7_HUMAN | RBBP7 | physical | 22863883 | |
| DHSO_HUMAN | SORD | physical | 22863883 | |
| TALDO_HUMAN | TALDO1 | physical | 22863883 | |
| WDR1_HUMAN | WDR1 | physical | 22863883 | |
| TRAF2_HUMAN | TRAF2 | physical | 25416956 | |
| SYNE2_HUMAN | SYNE2 | physical | 26344197 | |
| TRXR1_HUMAN | TXNRD1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-257 AND LYS-538, AND MASSSPECTROMETRY. | |